<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Suvorexant: Mechanism of Action, Therapeutic Uses & Adverse Effects</title>
  <meta name="description" content="Suvorexant: Mechanism of Action, Therapeutic Uses & Adverse Effects — Pharmacology Course" />
  <meta name="keywords" content="Suvorexant, Belsomra, orexin antagonist, insomnia, pharmacology, adverse effects" />
  <link rel="stylesheet" href="style.css">
</head>
<body>
  <header class="site-header">
    <div class="container">
      <div class="logo">
        <a href="index.html">Dr M Medical Courses</a>
      </div>
      <nav class="main-nav">
        <ul>
          <li><a href="index.html">Home</a></li>
          <li><a href="orthopedics.html">Orthopedics Courses</a></li>
          <li><a href="pharmacology.html">Pharmacology Courses</a></li>
          <li><a href="about.html">About</a></li>
        </ul>
      </nav>
    </div>
  </header>

  <main>
    <header>
      <h1>Suvorexant: Mechanism of Action, Therapeutic Uses & Adverse Effects</h1>
    </header>

    <section>
      <h2>Overview</h2>
      <ul>
        <li>Famous trade name: Belsomra</li>
        <li>It was first synthesized in 2006</li>
        <li>Suvorexant is an orexin receptor antagonist that is used in treatment of insomnia</li>
      </ul>
    </section>

    <hr />

    <section>
      <h2>Orexin</h2>
      <ul>
        <li>Orexin 1 and 2 are peptides which are available in some neurons in the hypothalamus and their function is promote wakefulness</li>
        <li>When there is higher level of orexin, those neurons get activated to keep the body awake, but when their levels falls then this lead to sleep</li>
        <li>Orexin receptor antagonists (suvorexant) work by antagonizing orexin so the body gets to sleep</li>
        <li>Suvorexant work by antagonizing both orexin 1 and 2 receptors</li>
      </ul>
    </section>

    <hr />

    <section>
      <h2>Therapeutic uses</h2>
      <ul>
        <li>Suvorexant is FDA approved for treatment of sleep onset and sleep maintenance insomnia</li>
      </ul>
    </section>

    <hr />

    <section>
      <h2>Adverse effects</h2>
      <ol>
        <li>Next day somnolence similar to narcolepsy
          <ul>
            <li>Narcolepsy is a disease that is characterized by loss of the orexin neurons leading to day time sleepiness, when antagonizing orexin, similar effect to narcolepsy happen</li>
          </ul>
        </li>
        <li>Headache, dizziness, abnormal dreams</li>
        <li>Dry mouth</li>
        <li>Rare: Sleep paralysis, hallucinations, complex sleep behaviors and suicidal ideation
          <ul>
            <li>Tolerance and dependence doesn’t occur with suvorexant</li>
          </ul>
        </li>
      </ol>
    </section>

    <hr />

    <section>
      <h2>Contraindications</h2>
      <ul>
        <li>Suvorexant is contraindicated in people with narcolepsy</li>
      </ul>
    </section>

    <hr />

    <section>
      <h2>Pharmacokinetics</h2>
      <ul>
        <li>Available as oral formula only</li>
        <li>Absorption is good with bioavailability of 82%</li>
        <li>It is metabolized by CYP3A4 enzymes in the liver, and it is liable to be affected by CYP3A4 inducers and inhibitors</li>
        <li>Elimination half life is around 12 hours</li>
        <li>Excretion: 60% through bile and the rest in urine</li>
      </ul>
    </section>

  </main>

  <footer>
    <p>&copy; 2025 Dr M. All Rights Reserved.</p>
  </footer>
</body>
</html>
